Mark B. Carbeau

Mark B. Carbeau

No más puestos en curso

63 años
Health Technology
Distribution Services
Commercial Services

Perfil

Mark B.
Carbeau
is the founder of CM Partners LLC, Diagnostyx, Inc. He was the Chief Executive Officer of Interleukin Genetics, Inc. in 2015, Chairman & Chief Executive Officer of Nuvesse Skin Therapies, Inc. in 2013, President & Chief Executive Officer of HyperMed, Inc. in 2008-2009, and President-USA Division of Kinetic Concepts, Inc. in 2005-2007.
He also worked as a Marketing Officer at Eli Lilly & Co. and as a Vice President-Corporate Development at OraPharma, Inc. He started his career as a Manager at The Boston Consulting Group, Inc. He holds an undergraduate degree from The Pennsylvania State University and an MBA from The Wharton School of the University of Pennsylvania.

Antiguos cargos conocidos de Mark B. Carbeau.

EmpresasCargoFin
INTERLEUKIN GENETICS, INC Director Ejecutivo 24/07/2017
Director Ejecutivo 01/06/2013
Director Ejecutivo 07/10/2009
Corporate Officer/Principal 30/06/2007
Director/Miembro de la Junta -
Ver el detalle de la experiencia de Mark B. Carbeau.

Formación de Mark B. Carbeau.

The Pennsylvania State University Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Mark B. Carbeau.

Relaciones

36

Relaciones de 1er grado

12

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas1
ELI LILLY AND COMPANY

Health Technology

Empresas privadas9

Health Technology

Health Technology

Health Technology

Distribution Services

Commercial Services

Commercial Services

Distribution Services

Diagnostyx, Inc.

Health Technology

Ver las conexiones de la empresa